Axsome Therapeutics CEO Herriot Tabuteau's 2021 pay rises 10% to $8.1M
Axsome Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 22, 2022
Axsome Therapeutics reported fiscal year 2021 executive compensation information on April 22, 2022.
In 2021, three executives at Axsome Therapeutics received on average a compensation package of $5.7M, a 57% increase compared to previous year.
Average pay of disclosed executives at Axsome Therapeutics
Herriot Tabuteau, Chief Executive Officer, received $8.1M in total, which increased by 10% compared to 2020. 58% of Tabuteau's compensation, or $4.7M, was in option awards. Tabuteau also received $349K in non-equity incentive plan, $685K in salary, $2.3M in stock awards, as well as $21K in other compensation.
For fiscal year 2021, the median employee pay was $690,964 at Axsome Therapeutics. Therefore, the ratio of Herriot Tabuteau's pay to the median employee pay was 12 to one.
Mark Jacobson, M.A, Chief Operating Officer, received a compensation package of $4.8M, which increased by 103% compared to previous year. 68% of the compensation package, or $3.2M, was in option awards.
Nick Pizzie, Chief Financial Officer, earned $4.2M in 2021, a 79% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2022.